MALAT1 and triple-negative breast carcinoma: Upregulation of lncRNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) was observed in persistence triple-negative breast cancer (TNBC) patients compared with that in extinction TNBC patients in response to neoadjuvant chemotherapy (NAC), suggesting a role of MALAT1 in conferring TNBC resistance to NAC therapy [22].